Steven Lichtman Stock Analyst Profile - Oppenheimer Research Coverage - Stocknear

Steven Lichtman

Stock Analyst at Oppenheimer

(3.7)
# 2397
Out of 5,506 analysts
80
Total ratings
Success rate
Average return

20 Stocks

Name Action PT Current % Upside Ratings Updated
TNDM Tandem Diabetes Care
Maintains: Outperform
44 22
14.71 49.56% 2 Sep 8, 2025
PODD Insulet
Maintains: Outperform
324 365
309.12 18.08% 5 Sep 8, 2025
BSX Boston Scientific
Upgrades: Outperform
118 125
97.31 28.46% 4 Sep 8, 2025
DXCM DexCom
Maintains: Outperform
95 102
67.05 52.13% 9 Jul 31, 2025
ZBH Zimmer Biomet Holdin...
Maintains: Outperform
145 135
100.78 33.96% 7 Oct 15, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
10 12
5.76 108.33% 2 Aug 28, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
103 110
77.39 42.14% 3 Aug 22, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Perform
92 94
97.7 -3.79% 10 Aug 21, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
72 65
8.8 638.64% 8 Aug 6, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
10 11
15.31 -28.15% 5 May 9, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Outperform
12
11.64 3.09% 2 Apr 5, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
82 87
84.21 3.31% 1 Feb 29, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Outperform
4
0.68 414.71% 2 Sep 19, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Perform
n/a
n/a n/a 9 May 9, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Perform
273 288
370.6 -22.29% 1 Jul 28, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Perform
105
87.39 20.15% 3 Jul 14, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Perform
150
27.14 452.69% 1 Jul 9, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Perform
83 85
70.46 20.64% 2 Sep 4, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Perform
n/a
n/a n/a 2 Dec 23, 2019
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Perform
n/a
n/a n/a 2 Apr 12, 2017